MarketCap
Facebook
X
TelegramQuarterly report 2022-Q3
added 11-14-2022
Tricida EV - Enterprise Value 2011-2026 | TCDA
Annual EV - Enterprise Value Tricida
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 506 M | 434 M | 1.7 B | 474 M | 1.66 M | 69.6 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.7 B | 1.66 M | 531 M |
EV - Enterprise Value of other stocks in the Drug manufacturers industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
6.79 M | - | 7.5 % | $ 6.35 M |  USA |
 |
Alimera Sciences
ALIM
|
197 M | - | - | $ 142 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
737 M | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
25.3 M | - | 10.11 % | $ 58.2 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
28.5 M | - | 0.86 % | $ 117 M | USA |
 |
Canopy Growth Corporation
CGC
|
459 M | $ 0.97 | 2.36 % | $ 104 M |  Canada |
 |
Aurora Cannabis
ACB
|
106 M | $ 3.31 | 1.53 % | $ 86.3 M | Canada |
 |
China Pharma Holdings
CPHI
|
11.1 M | $ 0.63 | 16.11 % | $ 11 M |  China |
 |
Catalent
CTLT
|
16.7 B | - | - | $ 11.5 B | USA |
 |
Athenex
ATNX
|
209 M | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
756 M | - | - | $ 2.06 B |  France |
 |
Cronos Group
CRON
|
3.84 B | $ 2.52 | 5.44 % | $ 1.31 B | Canada |
 |
DURECT Corporation
DRRX
|
3.37 M | - | - | $ 50.1 M | USA |
 |
Emergent BioSolutions
EBS
|
1.2 B | $ 8.05 | -1.71 % | $ 412 M | USA |
 |
Endo International plc
ENDP
|
-710 M | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
7.15 M | - | - | $ 36.6 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
10.2 M | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
284 M | - | 2.45 % | $ 38.1 M | Canada |
 |
Cumberland Pharmaceuticals
CPIX
|
124 M | $ 3.05 | 7.77 % | $ 42.9 M | USA |
 |
Bausch Health Companies
BHC
|
29.9 B | $ 5.1 | 1.8 % | $ 1.86 B | Canada |
 |
Harrow Health
HROW
|
2.21 B | $ 34.0 | 2.16 % | $ 1.25 B | USA |
 |
Assertio Holdings
ASRT
|
238 M | $ 14.0 | 4.71 % | $ 89.6 M | USA |
 |
OptiNose
OPTN
|
312 M | - | - | $ 1.08 B | USA |
 |
Evolus
EOLS
|
467 M | $ 4.68 | 0.86 % | $ 302 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
457 M | - | -39.89 % | $ 27.7 M | USA |
 |
Pacira BioSciences
PCRX
|
1.68 B | $ 22.65 | 2.44 % | $ 1.05 B | USA |
 |
OrganiGram Holdings
OGI
|
456 M | $ 1.36 | - | $ 402 M | Canada |
 |
PetIQ
PETQ
|
280 M | - | 1.64 % | $ 400 M | USA |
 |
PLx Pharma
PLXP
|
73.8 M | - | -27.8 % | $ 2.56 M | USA |
 |
ProPhase Labs
PRPH
|
145 M | - | - | $ 5.07 M | USA |
 |
Jupiter Wellness
JUPW
|
91.9 M | - | - | $ 33.6 M | USA |
 |
Radius Health
RDUS
|
700 M | - | - | $ 1.42 B | USA |
 |
Relmada Therapeutics
RLMD
|
251 M | $ 5.86 | -3.46 % | $ 231 M | USA |
 |
Rockwell Medical
RMTI
|
57.3 M | $ 1.02 | -2.86 % | $ 23.8 M | USA |
 |
Lannett Company
LCI
|
648 M | - | 1.15 % | $ 7.11 M | USA |
 |
Sundial Growers
SNDL
|
-17.5 M | $ 1.36 | 0.74 % | $ 3.37 M | Canada |
 |
SCYNEXIS
SCYX
|
26.3 M | $ 0.88 | -6.09 % | $ 43.9 M | USA |
 |
Solid Biosciences
SLDB
|
616 M | $ 7.14 | 1.56 % | $ 625 M | USA |
 |
Organogenesis Holdings
ORGO
|
392 M | $ 2.47 | 3.65 % | $ 325 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
-110 M | - | - | $ 193 M | Canada |
 |
Perrigo Company plc
PRGO
|
7.03 B | $ 9.57 | 3.46 % | $ 1.33 B | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
7.57 M | $ 2.55 | 4.94 % | $ 3.16 M | USA |
 |
Tilray
TLRY
|
1.96 B | $ 6.45 | 3.86 % | $ 3.99 B | Canada |
 |
Recro Pharma
REPH
|
220 M | - | -4.76 % | $ 65.3 M | USA |
 |
TherapeuticsMD
TXMD
|
33.6 M | $ 2.31 | 3.12 % | $ 24.1 M | USA |
 |
Veru
VERU
|
111 M | $ 2.3 | 1.32 % | $ 310 M | USA |
 |
Viatris
VTRS
|
41.3 B | $ 13.29 | 0.68 % | $ 16 B | USA |
 |
cbdMD
YCBD
|
7.85 M | $ 0.76 | 11.88 % | $ 3.28 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-22.6 M | - | - | $ 55.5 M | USA |